Cargando…
Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma
Multiple myeloma (MM) is a currently incurable hematologic cancer. Patients that initially respond to therapeutic intervention eventually relapse with drug resistant disease. Thus, novel treatment strategies are critically needed to improve patient outcomes. Our group has developed a novel cyclic pe...
Autores principales: | Elzamzamy, Osama M., Johnson, Brandon E., Chen, Wei-Chih, Hu, Gangqing, Penner, Reinhold, Hazlehurst, Lori A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231892/ https://www.ncbi.nlm.nih.gov/pubmed/34199280 http://dx.doi.org/10.3390/cells10061490 |
Ejemplares similares
-
The Role of TRPC1 in Modulating Cancer Progression
por: Elzamzamy, Osama M, et al.
Publicado: (2020) -
MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma
por: Emmons, Michael F., et al.
Publicado: (2017) -
Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines
por: Jones, Clark, et al.
Publicado: (2022) -
Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β‐hairpin‐like scaffold, MTI‐101
por: Jain, Priyesh, et al.
Publicado: (2020) -
Bridging the gap – MTI experience to an excellent MTI experience – An experiential, theme driven, concordance verifying study
por: Enara, Arun, et al.
Publicado: (2021)